RxDoctor Payments Data

Ronald Millman

Optometrist · Dover, NJNPI 1508825852

Payments from drug & device makers

$2,768in general payments, 2019–2025

Across 49 payments — averaging $56.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$1K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$348
  • Alcon$241
  • Tarsus Pharmaceuticals, Inc.$168
  • Bausch & Lomb Americas Inc.$154
  • AbbVie$130
  • plus $483 from 7 others

What the payments were for

  • Speaking & faculty fees$2509%
  • Food & beverage$2,49990%
  • Entertainment$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,768 in reported general payments places this provider in the 85th percentile of 1,357 optometrist providers in New Jersey.

See all optometrist providers in New Jersey

Medicare billing

Part B allowed, 2024
$50,487
Medicare patients
221
Services billed
607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate11$1,648
Tobramycin-DexamethasoneTobramycin/Dexamethasone21$630
Latanoprost12$100

Paid to pharmacies, not to this prescriber.

Other optometrist in Dover

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →